Compare ONON & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONON | HOLX |
|---|---|---|
| Founded | 2010 | 1985 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 16.9B |
| IPO Year | 2021 | 1995 |
| Metric | ONON | HOLX |
|---|---|---|
| Price | $35.60 | $76.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 20 | 13 |
| Target Price | $60.15 | ★ $77.89 |
| AVG Volume (30 Days) | 5.4M | ★ 33.2M |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | ★ $4,100,500,000.00 |
| Revenue This Year | $19.58 | $4.74 |
| Revenue Next Year | $19.98 | $5.03 |
| P/E Ratio | ★ $56.05 | $96.23 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $31.41 | $51.90 |
| 52 Week High | $61.29 | $76.07 |
| Indicator | ONON | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 46.21 | 69.09 |
| Support Level | $34.38 | $75.10 |
| Resistance Level | $37.89 | N/A |
| Average True Range (ATR) | 1.17 | 0.19 |
| MACD | 0.25 | 0.03 |
| Stochastic Oscillator | 51.90 | 95.19 |
Founded in Switzerland in 2010, sportswear firm On Holding generates 93% of its sales from athletic shoes. The brand is best known for its running shoes and its distinctive CloudTec soles. On also produces athletic apparel (6% of sales) and accessories (1%). The firm's merchandise is available in more than 80 countries and is sold through both wholesale (58% of sales) and company-owned channels (42%). In 2025, On generated 58% of its sales in North America, 25% in Europe, the Middle East, and Africa, and 17% in the Asia-Pacific region.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.